Tenon Medical (TNON) Q2 FY26 earnings call

Tenon Medical delivered a strong second quarter, achieving record revenue and significant gross margin expansion, primarily driven by increased surgical procedure volumes across its Catamaran and Symmetry Plus platforms. The company is actively investing in commercial expansion and R&D, with several product enhancements and new offerings in the pipeline, aiming to sustain growth and improve profitability. A recent public offering provided additional capital to fund these strategic priorities and partially repay convertible notes.